Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

NCT05621837 is registered in ClinicalTrials.gov with Fondazione IRCCS Istituto Nazionale dei Tumori, Milano as lead sponsor.

NCT NCT05621837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05621837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Lead sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Phase
Observational
Overall status
Recruiting
Start date
March 10, 2022
Completion date
December 31, 2026
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, melanoma, nsclc, renal cell carcinoma, small cell carcinoma, squamous cell carcinoma of head and neck, urinary bladder cancer